Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital

Endometrial scratch injury with office hysteroscopy before IVF/ICSI: A randomised controlled trial

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Co-treatment with letrozole during ovarian stimulation for IVF/ICSI: a systematic review and meta-analysis

    Research output: Contribution to journalReviewResearchpeer-review

  2. School performance in Danish children exposed to maternal type 1 diabetes in utero: A nationwide retrospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cardiovascular function in 8- to 9-year-old singletons born after ART with frozen and fresh embryo transfer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: Endometrial scratch injury (ESI) has been proposed to improve endometrial receptivity and thereby increase implantation rates in assisted reproductive technology (ART) treatment. ESI has been widely incorporated into clinical practice despite inconclusive evidence of its effect on reproductive outcomes. We aimed to assess pregnancy and live birth rates in subfertile women receiving ESI before IVF treatment in comparison to controls.

STUDY DESIGN: This was a randomised controlled trial (RCT) with no blinding of participants, investigators or health care personnel. Women in ART treatment were allocated to either office hysteroscopy with ESI (ESI group) or no intervention (control group). In total 184 women in IVF/ICSI treatment with minimum one previous failed IVF/ICSI cycle, were included in the final analysis. The primary outcome was positive serum hCG (s-hCG). Secondary outcomes were ongoing pregnancy and live birth rate. Only per-protocol analyses were performed as all patients included at one centre had to be excluded. The trial is registered at, NCT01743391.

RESULTS: Our results showed a non-significant increase in positive s-hCG (OR 1.23, 95 % CI (0.65-2.33)), ongoing pregnancy (OR 1.52, 95 % CI (0.73-3.17)), and live birth rates (OR 1.69, 95 % CI (0.78-3.64)) per randomised woman between the ESI and the control group.

CONCLUSION: We observed no significant differences in positive s-hCG or other reproductive outcomes in the ESI vs. the control group. While the crude estimates of positive reproductive outcomes were higher in the ESI group, statistical significance was not reached, and the study was not powered to show smaller differences. However, data from this study will be re-evaluated in the context of an individual participant data meta-analysis (IPD-MA) of RCTs on ESI.

Original languageEnglish
JournalEuropean journal of obstetrics, gynecology, and reproductive biology
Pages (from-to)112-117
Number of pages6
Publication statusPublished - 1 Sep 2020

ID: 60230318